🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.5 tsp Serving Size
47 Servings
Fat/Fatty Acid Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 {Calories}
Total Fat
2.5 Gram(s) (4% DV)
Cholesterol
10 mg (3% DV)
2216 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 2216mg UL 3000mg

Other Ingredients

Natural tutti-frutti flavor Rosemary Mixed Tocopherols Ascorbyl Palmitate Citric Acid Stevia

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Children 4 or More Years of Age

Product Information

📋 Directions for Use

Directions: Use only as directed. For children 4 years or older, take one-half teaspoon daily with a meal or as directed by your health care practitioner.

Shake well.

⚠️ Warnings & Precautions

Keep out of reach of children.

WARNING: Do not use if safety seal is broken or missing.

🧪 Formulation Notes

KIDS OMEGA-3

DHA 187 MG EPA 125 MG

Additional Information

Keep your licensed health care practitioner informed when using this product.

Product of Norway

Store in cool, dry place.

YUMMY TASTY LIQUID

MOLECULARLY DISTILLED TESTED FOR PURITY

Refrigerate after opening.

5973618 0410

Product Details

UPC / SKU 0 10043 05037 5
DSLD Entry Date 2014-06-25
Product Type Fat/Fatty Acid
Form Liquid
DSLD ID 34171
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →